How to buy EXACT Sciences Corporation stock (EXAS)

EXACT Sciences Corporation is a diagnostics & research business based in the US. EXACT Sciences Corporation shares (EXAS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $57.38 – a decrease of 6.32% over the previous week. EXACT Sciences Corporation employs 6,500 staff and has a trailing 12-month revenue of around $2.7 billion.

Our top picks for where to buy EXACT Sciences Corporation stock

Buy EXACT Sciences Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

EXACT Sciences Corporation stock price (NASDAQ: EXAS)

Use our graph to track the performance of EXAS stocks over time.

EXACT Sciences Corporation shares at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$57.38
52-week range	$40.62 - $79.62
50-day moving average more info button	$62.53
200-day moving average more info button	$58.26
Wall St. target price	$71.86
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.16

Is it a good time to buy EXACT Sciences Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

EXACT Sciences Corporation price performance over time

Historical closes compared with the close of $60.37 from 2024-12-17

1 week (2024-12-13)	-1.44%
1 month (2024-11-20)	14.55%
3 months (2024-09-20)	-13.87%
6 months (2024-06-20)	37.20%

1 year (2023-12-20)	-10.30%
2 years (2022-12-20)	18.16%
3 years (2021-12-20)	79.27
5 years (2019-12-20)	97.68

EXACT Sciences Corporation financials

Revenue TTM	$2.7 billion
Gross profit TTM	$1.5 billion
Return on assets TTM	-2.16%
Return on equity TTM	-6.76%
Profit margin	-7.95%
Book value	$17.35
Market Capitalization more info button	$10.6 billion

TTM: trailing 12 months

EXACT Sciences Corporation share dividends

We're not expecting EXACT Sciences Corporation to pay a dividend over the next 12 months.

EXACT Sciences Corporation share price volatility

Over the last 12 months, EXACT Sciences Corporation's shares have ranged in value from as little as $40.624 up to $79.62. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while EXACT Sciences Corporation's is 1.272. This would suggest that EXACT Sciences Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

EXACT Sciences Corporation overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. .

Frequently asked questions

null
What percentage of EXACT Sciences Corporation is owned by insiders or institutions?
Currently 1.011% of EXACT Sciences Corporation shares are held by insiders and 101.776% by institutions. How many people work for EXACT Sciences Corporation?
Latest data suggests 6,500 work at EXACT Sciences Corporation. When does the fiscal year end for EXACT Sciences Corporation?
EXACT Sciences Corporation's fiscal year ends in December. Where is EXACT Sciences Corporation based?
EXACT Sciences Corporation's address is: 5505 Endeavor Lane, Madison, WI, United States, 53719 What is EXACT Sciences Corporation's ISIN number?
EXACT Sciences Corporation's international securities identification number is: US30063P1057 What is EXACT Sciences Corporation's CUSIP number?
EXACT Sciences Corporation's Committee on Uniform Securities Identification Procedures number is: 30063P105